ALX Oncology Holdings Inc.
ALXO
$2.11
-$0.07-3.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.95M | -30.75M | -29.16M | -30.71M | -39.40M |
| Total Depreciation and Amortization | 191.00K | 211.00K | 214.00K | 224.00K | 220.00K |
| Total Amortization of Deferred Charges | 69.00K | 67.00K | 69.00K | 66.00K | 66.00K |
| Total Other Non-Cash Items | 5.46M | 5.17M | 5.59M | 6.36M | 6.34M |
| Change in Net Operating Assets | -3.17M | 645.00K | -8.76M | -1.32M | 6.21M |
| Cash from Operations | -23.41M | -24.66M | -32.05M | -25.38M | -26.57M |
| Capital Expenditure | -47.00K | -60.00K | -60.00K | -149.00K | -90.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.36M | 27.71M | 33.24M | 25.84M | 997.00K |
| Cash from Investing | 22.32M | 27.65M | 33.18M | 25.69M | 907.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -237.00K | -307.00K | -76.00K | -358.00K | -218.00K |
| Issuance of Common Stock | 15.00K | 372.00K | 45.00K | -- | 27.37M |
| Repurchase of Common Stock | -- | -- | -- | -29.59M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 359.00K | 30.20M | -- |
| Cash from Financing | -222.00K | 65.00K | 328.00K | 251.00K | 27.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.31M | 3.05M | 1.47M | 568.00K | 1.49M |